Crestline Management’s Nu Skin NUS Stock Holding History

Crestline Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,000	Closed	-$2M	–	166
2020 Q3	$2M	Buy	+40,000	New	+$1.9M	0.3%	50

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Crestline Management's NUS Position: Q4 2020 in Review

Crestline Management sold out of Nu Skin (NUS) in Q4 2020, closing a stake of 40,000 shares — an estimated $2M sold.

Crestline Management first reported a position in NUS in Q3 2020 and held it in 1 quarter. The position peaked at $2M in Q3 2020. 266 funds tracked by Wall St. Rank hold NUS as of Q4 2020.

Crestline Management reported no remaining Nu Skin position as of Q4 2020 after selling out during the quarter.
Crestline Management sold 40,000 Nu Skin shares in Q4 2020, an estimated $2M.
Crestline Management first reported a position in Nu Skin in Q3 2020 and held it in 1 quarter.
Crestline Management's Nu Skin position peaked at $2M in Q3 2020.
266 funds tracked by Wall St. Rank held Nu Skin as of Q4 2020.

Based on Crestline Management's 13F filing for Q4 2020, filed 12 Feb 2021.